![](/img/cover-not-exists.png)
Suppressive activity rather than frequency of FoxP3+ regulatory T cells is essential for CA-125–specific T-cell activation after abagovomab treatment
Silke Reinartz, Jacobus Pfisterer, Andreas du Bois, Christian Jackisch, Klaus H. Baumann, Uwe WagnerVolume:
71
Year:
2010
Language:
english
DOI:
10.1016/j.humimm.2009.09.356
File:
PDF, 1.26 MB
english, 2010